mr PHILIP KLEIN

H.R. 1029, the Pesticide Registration Enhancement Act of 2017 - CSPA is part of a broad-based coalition comprised of companies that rely on the registration process, farm workers and environmental advocates that actively support passage of the bill. CSPA representatives met with Members and professional staff of the House and Senate Agriculture Committees. Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) - CSPA representatives met with professional staff of the Senate and House Agriculture Committees, the House and Senate Appropriations Committees and the U.S. Environmental Protection Agency (EPA) to discuss implementation of the Pesticide Registration Improvement Extension Act of 2012 (7 U.S.C. 136w-8). EPA Safer Choice program - CSPA representatives contacted the professional staff of the Senate and House Appropriations Committees urging adequate funding for the program. CSPA met with senior EPA staff to discuss ways to build more flexibility into the Safer Choice program and to develop a path for antimicrobials to be included in the program. CSPA led a broad coalition of 182 companies, trade associations and retailers that expressed united support for the Safer Choice Program in a letter to Administrator Pruitt. Implementing the Frank R. Lautenberg Chemical Safety for the 21st Century Act (Pub. L. No. 114-182) - CSPA representatives met with EPA staff and OMB staff to discuss provisions of the new law related to risk-based procedures for chemical prioritization for risk evaluation and the collection of fees for administering risk evaluations (Section 6), use reporting (Sec. 8) and confidential business information (Sec. 14). S. 263 and H.R. 806, the Ozone Standards Implementation Act of 2017 - CSPA representatives met with the House Energy and Commerce Committee staff to express concerns about the feasibility of complying with the deadlines for implementing the 2015 National Ambient Air Quality Standards for Ozone. Preventing the spread of the Zika Virus - CSPA representatives met with senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce to discuss CSPA member companies work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention to prevent the spread of Zika in the United States.

H.R. 1029, the Pesticide Registration Improvement Extension Act of 2017 - CSPA is part of a broad-based coalition comprised of companies that rely on the pesticide registration process, farm workers and environmental advocates that actively support passage of the bill. CSPA representatives met with Members and professional staff of the House and Senate Agriculture Committees. Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) - CSPA representatives met with professional staff of the Senate and House Agriculture Committees, the House and Senate Appropriations Committees and the U.S. Environmental Protection Agency (EPA) to discuss implementation of the Pesticide Registration Improvement Extension Act of 2012 (7 U.S.C. 136w-8). EPA Safer Choice program - CSPA representatives met with a Member, the personal staff of two Members and the professional staff of the Senate and House Appropriations Committees urging adequate funding for the program. CSPA met with Administrator Pruitt and senior EPA staff to: (1) express support for the program, (2) discuss ways to build more flexibility into the Safer Choice program, and (3) develop a path for antimicrobials to be included in the program. Implementing the Frank R. Lautenberg Chemical Safety for the 21st Century Act (Pub. L. No. 114-182) - CSPA representatives met with EPA staff to discuss provisions of the new law related to risk-based procedures for chemical prioritization for risk evaluation and the collection of fees for administering risk evaluations (Section 6), use reporting (Sec. 8) and confidential business information (Sec. 14). S. 263 and H.R. 806, the Ozone Standards Implementation Act of 2017 - the two bills would establish a more reasonable timeframe for implementing the 2015 ozone standards and would change the review cycle for the National Ambient Air Quality Standards (NAAQS) from five years to 10 years. CSPA representatives met with a Member and his personal staff to expressed support for the House bill and articulated our concerns about the feasibility of complying with the current deadlines for implementing the 2015 NAAQS for Ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) - met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012 (7 U.S.C. 136w-8). CSPA leads a coalition effort supporting reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Preventing the spread of the Zika Virus - met with senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce to discuss CSPA member companies work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention to prevent the spread of Zika in the United States. Frank R. Lautenberg Chemical Safety for the 21st Century Act, Pub. L. No. 114-182 - met with senior EPA staff to discuss the Agencys general plans for implementing provisions of the new law related to use reporting (Sec. 8) and confidential business information (Sec. 14). EPA Safer Choice program - contacted the professional staff of the Senate and House Appropriations Committees urging adequate funding for the program. In addition, CSPA met with senior EPA staff to discuss ways to build more flexibility into the Safer Choice program and to develop a path for antimicrobials to be included in the program. H.R. 4909, the National Defense Authorization Act (NDAA) for Fiscal Year 2017 - contacted Members and professional staff of the Senate Committee on Armed Services and the House Committee on Armed Services advocating against a provision known as the Fleming Amendment. CSPA expressed concerns that the amendment would prohibit the Department of Defense from using authorized funds to implement Executive Order 13693 (Planning for Federal Sustainability in the Next Decade), which includes, among other things, the EPA Safer Choice program. H.R. 4775, the Ozone Standards Implementation Act and S. 2882, the Ozone Standards Implementation Act of 2016 (the companion bill to H.R. 4775) - expressed concerns about the feasibility of the 2015 National Ambient Air Quality Standard for Ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) - CSPA representatives met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012 (7 U.S.C. 136w-8). CSPA leads a coalition effort supporting reauthorization of the Act (PRIA 4) and met with Members and professional staff of the House and Senate Appropriations Committees. Implementing the Frank R. Lautenberg Chemical Safety for the 21st Century Act (Pub. L. No. 114-182) - CSPA representatives met with EPA staff and OMB staff to discuss provisions of the new law related to risk-based procedures for chemical prioritization for risk evaluation and the collection of fees for administering risk evaluations (Section 6), use reporting (Sec. 8) and confidential business information (Sec. 14). EPA Safer Choice program - CSPA representatives contacted the professional staff of the Senate and House Appropriations Committees urging adequate funding for the program. In addition, CSPA met with senior EPA staff to discuss ways to build more flexibility into the Safer Choice program and to develop a path for antimicrobials to be included in the program. Preventing the spread of the Zika Virus - CSPA representatives met with senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce to discuss CSPA member companies work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention to prevent the spread of Zika in the United States. H.R. 4909, the National Defense Authorization Act (NDAA) for Fiscal Year 2017 - CSPA representatives contacted Members and professional staff of the Senate Committee on Armed Services and the House Committee on Armed Services advocating against a provision known as the Fleming Amendment. CSPA expressed concerns that the amendment would prohibit the Department of Defense from using authorized funds to implement Executive Order 13693 (Planning for Federal Sustainability in the Next Decade), which includes, among other things, the EPA Safer Choice program. H.R. 4775, the Ozone Standards Implementation Act and S. 2882, the Ozone Standards Implementation Act of 2016 (the companion bill to H.R. 4775) - CSPA representatives expressed member companies concerns about the feasibility and cost of complying with the 2015 National Ambient Air Quality Standard for Ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) - CSPA representatives met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012 (7 U.S.C. 136w-8). CSPA leads a coalition effort supporting reauthorization of the Act (PRIA 4) and met with Members and professional staff of the House and Senate Appropriations Committees. Implementing the Frank R. Lautenberg Chemical Safety for the 21st Century Act (Pub. L. No. 114-182) - CSPA representatives met with EPA staff and OMB staff to discuss provisions of the new law related to risk-based procedures for chemical prioritization for risk evaluation and the collection of fees for administering risk evaluations (Section 6), use reporting (Sec. 8) and confidential business information (Sec. 14). EPA Safer Choice program - CSPA representatives contacted the professional staff of the Senate and House Appropriations Committees urging adequate funding for the program. In addition, CSPA met with senior EPA staff to discuss ways to build more flexibility into the Safer Choice program and to develop a path for antimicrobials to be included in the program. Preventing the spread of the Zika Virus - CSPA representatives met with senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce to discuss CSPA member companies work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention to prevent the spread of Zika in the United States. H.R. 4909, the National Defense Authorization Act (NDAA) for Fiscal Year 2017 - CSPA representatives contacted Members and professional staff of the Senate Committee on Armed Services and the House Committee on Armed Services advocating against a provision known as the Fleming Amendment. CSPA expressed concerns that the amendment would prohibit the Department of Defense from using authorized funds to implement Executive Order 13693 (Planning for Federal Sustainability in the Next Decade), which includes, among other things, the EPA Safer Choice program. H.R. 4775, the Ozone Standards Implementation Act and S. 2882, the Ozone Standards Implementation Act of 2016 (the companion bill to H.R. 4775) - CSPA representatives expressed member companies concerns about the feasibility and cost of complying with the 2015 National Ambient Air Quality Standard for Ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) - met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012 (7 U.S.C. 136w-8). CSPA leads a coalition effort supporting reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Preventing the spread of the Zika Virus - met with senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce to discuss CSPA member companies work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention to prevent the spread of Zika in the United States. Frank R. Lautenberg Chemical Safety for the 21st Century Act, Pub. L. No. 114-182 - met with senior EPA staff to discuss the Agencys general plans for implementing provisions of the new law related to use reporting (Sec. 8) and confidential business information (Sec. 14). EPA Safer Choice program - contacted the professional staff of the Senate and House Appropriations Committees urging adequate funding for the program. In addition, CSPA met with senior EPA staff to discuss ways to build more flexibility into the Safer Choice program and to develop a path for antimicrobials to be included in the program. H.R. 4909, the National Defense Authorization Act (NDAA) for Fiscal Year 2017 - contacted Members and professional staff of the Senate Committee on Armed Services and the House Committee on Armed Services advocating against a provision known as the Fleming Amendment. CSPA expressed concerns that the amendment would prohibit the Department of Defense from using authorized funds to implement Executive Order 13693 (Planning for Federal Sustainability in the Next Decade), which includes, among other things, the EPA Safer Choice program. H.R. 4775, the Ozone Standards Implementation Act and S. 2882, the Ozone Standards Implementation Act of 2016 (the companion bill to H.R. 4775) - expressed concerns about the feasibility of the 2015 National Ambient Air Quality Standard for Ozone.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) - CSPA representatives met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012 (7 U.S.C. 136w-8). CSPA leads a coalition effort supporting reauthorization of the Act (PRIA 4) and met with Members and professional staff of the House and Senate Appropriations Committees. Implementing the Frank R. Lautenberg Chemical Safety for the 21st Century Act (Pub. L. No. 114-182) - CSPA representatives met with EPA staff and OMB staff to discuss provisions of the new law related to risk-based procedures for chemical prioritization for risk evaluation and the collection of fees for administering risk evaluations (Section 6), use reporting (Sec. 8) and confidential business information (Sec. 14). EPA Safer Choice program - CSPA representatives contacted the professional staff of the Senate and House Appropriations Committees urging adequate funding for the program. In addition, CSPA met with senior EPA staff to discuss ways to build more flexibility into the Safer Choice program and to develop a path for antimicrobials to be included in the program. Preventing the spread of the Zika Virus - CSPA representatives met with senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce to discuss CSPA member companies work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention to prevent the spread of Zika in the United States. H.R. 4909, the National Defense Authorization Act (NDAA) for Fiscal Year 2017 - CSPA representatives contacted Members and professional staff of the Senate Committee on Armed Services and the House Committee on Armed Services advocating against a provision known as the Fleming Amendment. CSPA expressed concerns that the amendment would prohibit the Department of Defense from using authorized funds to implement Executive Order 13693 (Planning for Federal Sustainability in the Next Decade), which includes, among other things, the EPA Safer Choice program. H.R. 4775, the Ozone Standards Implementation Act and S. 2882, the Ozone Standards Implementation Act of 2016 (the companion bill to H.R. 4775) - CSPA representatives expressed member companies concerns about the feasibility and cost of complying with the 2015 National Ambient Air Quality Standard for Ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) - met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012 (7 U.S.C. 136w-8). CSPA leads a coalition effort supporting reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Preventing the spread of the Zika Virus - met with senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce to discuss CSPA member companies work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention to prevent the spread of Zika in the United States. Frank R. Lautenberg Chemical Safety for the 21st Century Act, Pub. L. No. 114-182 - met with senior EPA staff to discuss the Agencys general plans for implementing provisions of the new law related to use reporting (Sec. 8) and confidential business information (Sec. 14). EPA Safer Choice program - contacted the professional staff of the Senate and House Appropriations Committees urging adequate funding for the program. In addition, CSPA met with senior EPA staff to discuss ways to build more flexibility into the Safer Choice program and to develop a path for antimicrobials to be included in the program. H.R. 4909, the National Defense Authorization Act (NDAA) for Fiscal Year 2017 - contacted Members and professional staff of the Senate Committee on Armed Services and the House Committee on Armed Services advocating against a provision known as the Fleming Amendment. CSPA expressed concerns that the amendment would prohibit the Department of Defense from using authorized funds to implement Executive Order 13693 (Planning for Federal Sustainability in the Next Decade), which includes, among other things, the EPA Safer Choice program. H.R. 4775, the Ozone Standards Implementation Act and S. 2882, the Ozone Standards Implementation Act of 2016 (the companion bill to H.R. 4775) - expressed concerns about the feasibility of the 2015 National Ambient Air Quality Standard for Ozone.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. Briefed professional staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention on issues related to preventing the spread of the Zika Virus. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone: H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act; H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

CSPA expressed our member companies consensus positions on Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, CSPA staff met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4) and met with members of the House and Senate Appropriations Committees. CSPA worked on issues related to preventing the spread of the Zika Virus and briefed senior staff of the Senate and House Committees on Agriculture and the House Committee on Energy and Commerce about CSPAs work with the EPA, the Department of Health & Human Services and the Centers for Disease Control and Prevention. CSPA supported Congressional action to modernize the Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continued adequate funding for the EPA Safer Choice program. CSPA also met with senior EPA staff to discuss the Safer Choice program. CSPA supports Congressional action challenging the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone because our member companies have serious concerns about the feasibility of the EPA regulation. CSPA advocacy actions focused primarily on H.R. 4775, the Ozone Standards Implementation Act, a bill that would (among other things) extend the review cycle from five to ten years for NAAQS under the Clean Air Act and S. 2882, the Ozone Standards Implementation Act of 2016. CSPA monitored other bills, including: H.J. Res. 74 and S.J. Res. 25, Congressional Review Act resolutions that would nullify the EPA final rule revising the NAAQS for ozone; H.R. 4265, the Clean Air Implementation Act, a bill that would increase the period for reviewing NAAQS from five years to eight years; H.R. 1388 and S. 751, the Clean Air, Strong Economies (CASE) Act, a bill that would prohibit EPA from lowering the ozone standard until at least 85% of counties that are currently in nonattainment achieve full compliance with the 2008 ozone standard; H.R. 1320 and S. 638, the Commonsense Legislative Exceptional Events Reform (CLEER) Act, a bill to delay the review and revision of the NAAQS for ozone; H.R. 1327 and S. 640, the Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act, a bill to amend the federal Clean Air Act to delay review and revision of the NAAQS for ozone; S. 2072, a bill to require EPA to establish a program to defer designations of non-attainment area if the area achieves and maintains certain standards under a voluntary early action compact plan; and H.R. 4000, the Ozone NAAQS Deadline Harmonization Act, a bill that would harmonize the requirements of the 2008 and 2015 ozone standards and establish a workable implementation schedule for the 2015 standard.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4). The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone. Specifically, S. 751, the Clean Air, Strong Economies (CASE) Act, H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards; S. 638, the Commonsense Legislative Exceptional Events Reform Act; H.R. 1320, a bill to delay the review and revision of the NAAQS for ozone, H.R. 1327, a bill to amend the Clean Air Act to delay review and revision of the NAAQS for ozone; H.J. Res. 74, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone; and S. J. Res. 25, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), including PRIA reauthorization and Section 25(b) products; (2) Pollution Prevention Act (PPA), including the EPA Safer Choice program (formerly known as Design for the Environment); (3) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R 2576; (4) EPA Ozone Standard, specifically S. 751, S. 638, S. 640, H.R. 1388, H.R. 1327, H.R. 1320; (5) Consumer Products Safety Act (CPSA); (6) Occupational Safety and Health (OSH) Act; and (7) Federal Trade Commissions Green Guides.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4). The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone. Specifically, S. 751, the Clean Air, Strong Economies (CASE) Act, H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards; S. 638, the Commonsense Legislative Exceptional Events Reform Act; H.R. 1320, a bill to delay the review and revision of the NAAQS for ozone, H.R. 1327, a bill to amend the Clean Air Act to delay review and revision of the NAAQS for ozone; H.J. Res. 74, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone; and S. J. Res. 25, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. Furthermore, CSPA is leading a coalition to support reauthorization of the Act. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act. CSPA addressed provisions of the bill related to use reporting, confidential business information, and preemption. In addition, CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Met with professional staff of the Senate Environment and Public Works Committee and the House Energy and Commerce Committee to discuss provisions of the following bills related to the EPA proposal to revise the National Ambient Air Quality Standards (NAAQS) for ground-level ozone: S. 751, the Clean Air, Strong Economies (CASE), H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards, and for other purposes; S. 638, the Commonsense Legislative Exceptional Events Reforms Act, H.R. 1320, A bill to amend the Clean Air Act with respect to exceptional event demonstrations, and for other purposes; S. 640, a bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone; and H.R. 1327, A bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), including PRIA reauthorization and Section 25(b) products; (2) Pollution Prevention Act (PPA), including the EPA Safer Choice program (formerly known as Design for the Environment); (3) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R 2576; (4) EPA Ozone Standard, specifically S. 751, S. 638, S. 640, H.R. 1388, H.R. 1327, H.R. 1320; (5) Consumer Products Safety Act (CPSA); (6) Occupational Safety and Health (OSH) Act; and (7) Federal Trade Commissions Green Guides.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4). The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone. Specifically, S. 751, the Clean Air, Strong Economies (CASE) Act, H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards; S. 638, the Commonsense Legislative Exceptional Events Reform Act; H.R. 1320, a bill to delay the review and revision of the NAAQS for ozone, H.R. 1327, a bill to amend the Clean Air Act to delay review and revision of the NAAQS for ozone; H.J. Res. 74, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone; and S. J. Res. 25, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. Furthermore, CSPA is leading a coalition to support reauthorization of the Act. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act. CSPA addressed provisions of the bill related to use reporting, confidential business information, and preemption. In addition, CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Met with professional staff of the Senate Environment and Public Works Committee and the House Energy and Commerce Committee to discuss provisions of the following bills related to the EPA proposal to revise the National Ambient Air Quality Standards (NAAQS) for ground-level ozone: S. 751, the Clean Air, Strong Economies (CASE), H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards, and for other purposes; S. 638, the Commonsense Legislative Exceptional Events Reforms Act, H.R. 1320, A bill to amend the Clean Air Act with respect to exceptional event demonstrations, and for other purposes; S. 640, a bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone; and H.R. 1327, A bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. Furthermore, CSPA is leading a coalition to support reauthorization of the Act. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act. CSPA addressed provisions of the bill related to use reporting, confidential business information, and preemption. In addition, CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Met with professional staff of the Senate Environment and Public Works Committee and the House Energy and Commerce Committee to discuss provisions of the following bills related to the EPA proposal to revise the National Ambient Air Quality Standards (NAAQS) for ground-level ozone: S. 751, the Clean Air, Strong Economies (CASE), H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards, and for other purposes; S. 638, the Commonsense Legislative Exceptional Events Reforms Act, H.R. 1320, A bill to amend the Clean Air Act with respect to exceptional event demonstrations, and for other purposes; S. 640, a bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone; and H.R. 1327, A bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), including PRIA reauthorization and Section 25(b) products; (2) Pollution Prevention Act (PPA), including the EPA Safer Choice program (formerly known as Design for the Environment); (3) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R 2576; (4) EPA Ozone Standard, specifically S. 751, S. 638, S. 640, H.R. 1388, H.R. 1327, H.R. 1320; (5) Consumer Products Safety Act (CPSA); (6) Occupational Safety and Health (OSH) Act; and (7) Federal Trade Commissions Green Guides.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4). The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone. Specifically, S. 751, the Clean Air, Strong Economies (CASE) Act, H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards; S. 638, the Commonsense Legislative Exceptional Events Reform Act; H.R. 1320, a bill to delay the review and revision of the NAAQS for ozone, H.R. 1327, a bill to amend the Clean Air Act to delay review and revision of the NAAQS for ozone; H.J. Res. 74, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone; and S. J. Res. 25, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), including PRIA reauthorization and Section 25(b) products; (2) Pollution Prevention Act (PPA), including the EPA Safer Choice program (formerly known as Design for the Environment); (3) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R 2576; (4) EPA Ozone Standard, specifically S. 751, S. 638, S. 640, H.R. 1388, H.R. 1327, H.R. 1320; (5) Consumer Products Safety Act (CPSA); (6) Occupational Safety and Health (OSH) Act; and (7) Federal Trade Commissions Green Guides.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4). The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone. Specifically, S. 751, the Clean Air, Strong Economies (CASE) Act, H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards; S. 638, the Commonsense Legislative Exceptional Events Reform Act; H.R. 1320, a bill to delay the review and revision of the NAAQS for ozone, H.R. 1327, a bill to amend the Clean Air Act to delay review and revision of the NAAQS for ozone; H.J. Res. 74, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone; and S. J. Res. 25, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4). The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone. Specifically, S. 751, the Clean Air, Strong Economies (CASE) Act, H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards; S. 638, the Commonsense Legislative Exceptional Events Reform Act; H.R. 1320, a bill to delay the review and revision of the NAAQS for ozone, H.R. 1327, a bill to amend the Clean Air Act to delay review and revision of the NAAQS for ozone; H.J. Res. 74, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone; and S. J. Res. 25, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. Furthermore, CSPA is leading a coalition to support reauthorization of the Act. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act. CSPA addressed provisions of the bill related to use reporting, confidential business information, and preemption. In addition, CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Met with professional staff of the Senate Environment and Public Works Committee and the House Energy and Commerce Committee to discuss provisions of the following bills related to the EPA proposal to revise the National Ambient Air Quality Standards (NAAQS) for ground-level ozone: S. 751, the Clean Air, Strong Economies (CASE), H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards, and for other purposes; S. 638, the Commonsense Legislative Exceptional Events Reforms Act, H.R. 1320, A bill to amend the Clean Air Act with respect to exceptional event demonstrations, and for other purposes; S. 640, a bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone; and H.R. 1327, A bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), including PRIA reauthorization and Section 25(b) products; (2) Pollution Prevention Act (PPA), including the EPA Safer Choice program (formerly known as Design for the Environment); (3) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R 2576; (4) EPA Ozone Standard, specifically S. 751, S. 638, S. 640, H.R. 1388, H.R. 1327, H.R. 1320; (5) Consumer Products Safety Act (CPSA); (6) Occupational Safety and Health (OSH) Act; and (7) Federal Trade Commissions Green Guides.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), including PRIA reauthorization and Section 25(b) products; (2) Pollution Prevention Act (PPA), including the EPA Safer Choice program (formerly known as Design for the Environment); (3) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R 2576; (4) EPA Ozone Standard, specifically S. 751, S. 638, S. 640, H.R. 1388, H.R. 1327, H.R. 1320; (5) Consumer Products Safety Act (CPSA); (6) Occupational Safety and Health (OSH) Act; and (7) Federal Trade Commissions Green Guides.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. Furthermore, CSPA is leading a coalition to support reauthorization of the Act. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act. CSPA addressed provisions of the bill related to use reporting, confidential business information, and preemption. In addition, CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Met with professional staff of the Senate Environment and Public Works Committee and the House Energy and Commerce Committee to discuss provisions of the following bills related to the EPA proposal to revise the National Ambient Air Quality Standards (NAAQS) for ground-level ozone: S. 751, the Clean Air, Strong Economies (CASE), H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards, and for other purposes; S. 638, the Commonsense Legislative Exceptional Events Reforms Act, H.R. 1320, A bill to amend the Clean Air Act with respect to exceptional event demonstrations, and for other purposes; S. 640, a bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone; and H.R. 1327, A bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. Furthermore, CSPA is leading a coalition to support reauthorization of the Act. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act. CSPA addressed provisions of the bill related to use reporting, confidential business information, and preemption. In addition, CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Met with professional staff of the Senate Environment and Public Works Committee and the House Energy and Commerce Committee to discuss provisions of the following bills related to the EPA proposal to revise the National Ambient Air Quality Standards (NAAQS) for ground-level ozone: S. 751, the Clean Air, Strong Economies (CASE), H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards, and for other purposes; S. 638, the Commonsense Legislative Exceptional Events Reforms Act, H.R. 1320, A bill to amend the Clean Air Act with respect to exceptional event demonstrations, and for other purposes; S. 640, a bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone; and H.R. 1327, A bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Consumer Products Safety Act (CPSA); (2) Federal Insecticide, fungicide, and Rodenticide Act (FIFRA); (3) Occupational Safety and Health (OSH) Act; Pollution Prevention Act (PPA); and (5) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R ___, the TSCA Modernization Act of 2015.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), including PRIA reauthorization and Section 25(b) products; (2) Pollution Prevention Act (PPA), including the EPA Safer Choice program (formerly known as Design for the Environment); (3) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R 2576; (4) EPA Ozone Standard, specifically S. 751, S. 638, S. 640, H.R. 1388, H.R. 1327, H.R. 1320; (5) Consumer Products Safety Act (CPSA); (6) Occupational Safety and Health (OSH) Act; and (7) Federal Trade Commissions Green Guides.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Consumer Products Safety Act (CPSA); (2) Federal Insecticide, fungicide, and Rodenticide Act (FIFRA); (3) Occupational Safety and Health (OSH) Act; Pollution Prevention Act (PPA); and (5) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R ___, the TSCA Modernization Act of 2015.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4). The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone. Specifically, S. 751, the Clean Air, Strong Economies (CASE) Act, H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards; S. 638, the Commonsense Legislative Exceptional Events Reform Act; H.R. 1320, a bill to delay the review and revision of the NAAQS for ozone, H.R. 1327, a bill to amend the Clean Air Act to delay review and revision of the NAAQS for ozone; H.J. Res. 74, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone; and S. J. Res. 25, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Consumer Products Safety Act (CPSA); (2) Federal Insecticide, fungicide, and Rodenticide Act (FIFRA); (3) Occupational Safety and Health (OSH) Act; Pollution Prevention Act (PPA); and (5) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R ___, the TSCA Modernization Act of 2015.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Consumer Products Safety Act (CPSA); (2) Federal Insecticide, fungicide, and Rodenticide Act (FIFRA); (3) Occupational Safety and Health (OSH) Act; Pollution Prevention Act (PPA); and (5) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R ___, the TSCA Modernization Act of 2015.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), including PRIA reauthorization and Section 25(b) products; (2) Pollution Prevention Act (PPA), including the EPA Safer Choice program (formerly known as Design for the Environment); (3) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R 2576; (4) EPA Ozone Standard, specifically S. 751, S. 638, S. 640, H.R. 1388, H.R. 1327, H.R. 1320; (5) Consumer Products Safety Act (CPSA); (6) Occupational Safety and Health (OSH) Act; and (7) Federal Trade Commissions Green Guides.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4). The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone. Specifically, S. 751, the Clean Air, Strong Economies (CASE) Act, H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards; S. 638, the Commonsense Legislative Exceptional Events Reform Act; H.R. 1320, a bill to delay the review and revision of the NAAQS for ozone, H.R. 1327, a bill to amend the Clean Air Act to delay review and revision of the NAAQS for ozone; H.J. Res. 74, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone; and S. J. Res. 25, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. Furthermore, CSPA is leading a coalition to support reauthorization of the Act. The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act. CSPA addressed provisions of the bill related to use reporting, confidential business information, and preemption. In addition, CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Met with professional staff of the Senate Environment and Public Works Committee and the House Energy and Commerce Committee to discuss provisions of the following bills related to the EPA proposal to revise the National Ambient Air Quality Standards (NAAQS) for ground-level ozone: S. 751, the Clean Air, Strong Economies (CASE), H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards, and for other purposes; S. 638, the Commonsense Legislative Exceptional Events Reforms Act, H.R. 1320, A bill to amend the Clean Air Act with respect to exceptional event demonstrations, and for other purposes; S. 640, a bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone; and H.R. 1327, A bill to amend the Clean Air Act to delay the review and revision of the national ambient air quality standards for ozone.

Proposed legislation and Congressional oversight of regulatory matters related to: (1) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), including PRIA reauthorization and Section 25(b) products; (2) Pollution Prevention Act (PPA), including the EPA Safer Choice program (formerly known as Design for the Environment); (3) Toxic Substances Control Act (TSCA), specifically S. 697, S. 725 and H.R 2576; (4) EPA Ozone Standard, specifically S. 751, S. 638, S. 640, H.R. 1388, H.R. 1327, H.R. 1320; (5) Consumer Products Safety Act (CPSA); (6) Occupational Safety and Health (OSH) Act; and (7) Federal Trade Commissions Green Guides.

Congressional oversight of regulatory matters related to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, met with professional staff of the Senate and House Agriculture Committees and the U.S. Environmental Protection Agency (EPA) to discuss issues related to the implementation of the Pesticide Registration Improvement Extension Act (PRIA 3) of 2012. CSPA is leading a coalition to support reauthorization of the Act (PRIA 4). The Toxic Substances Control Act (TSCA), specifically S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and H.R. 2576, the TSCA Modernization Act of 2015. CSPA addressed provisions of the two bills related to use reporting (TSCA 8), confidential business information (TSCA 14), and preemption (TSCA 18). CSPA contacted the professional staff of the Senate and House Appropriations Committees to support continue adequate funding for the EPA Safer Choice / Design for the Environment (DfE) program. CSPA also met with senior EPA staff to discuss the Safer Choice / DfE program. Legislation to review and delay implementation of the new National Ambient Air Quality Standard (NAAQS) for ground-level ozone. Specifically, S. 751, the Clean Air, Strong Economies (CASE) Act, H.R. 1388, a bill to improve the establishment of any lower ground-level ozone standards; S. 638, the Commonsense Legislative Exceptional Events Reform Act; H.R. 1320, a bill to delay the review and revision of the NAAQS for ozone, H.R. 1327, a bill to amend the Clean Air Act to delay review and revision of the NAAQS for ozone; H.J. Res. 74, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone; and S. J. Res. 25, a joint revision providing for Congressional disapproval of the EPA final rule relating to the NAAQS for ozone.

TSCA Oversight and Regulatory Issues/USEPA; S. 1009, Chemical Safety Improvement Act, legislation to update federal laws to manage chemical safety as it pertains to products that use the chemicals. Pesticide regulations and oversight at the USEPA; implementation of the National Ambient Air Quality Act as it pertains to the restriction of certain emissions.

TSCA oversight and regulatory matters/USEPA; S. 1009/Chemical Safety Improvement Act; Pesticide Registration Improvement Act oversight and regulatory matters; US EPA national ambient air quality issues/VOCs

TSCA Oversight and Regulatory Issues/USEPA; S. 1009, Chemical Safety Improvement Act, legislation to update federal laws to manage chemical safety as it pertains to products that use the chemicals. Pesticide regulations and oversight at the USEPA; implementation of the National Ambient Air Quality Act as it pertains to the restriction of certain emissions.

TSCA oversight and regulatory matters/USEPA; S. 1009/Chemical Safety Improvement Act; Pesticide Registration Improvement Act oversight and regulatory matters; US EPA national ambient air quality issues/VOCs

TSCA oversight and implementation/US EPA, US Senate and US House; S. 1009, the Chemical Safety Improvement Act. Pesticide Registration Improvement Act (PRIA) oversight, implementation and funding/US EPA, US Senate and US House. US EPA, national ambient air quality issues. OSHA, implementaiton of Global Harmonization and Classifications Act (GHS).

Product safety and product care; public health and safety as part of TSCA, S. 847, S 1009

Toxic Substances Control Act: S. 1009, S 847, Pesticides Policy and Implementation of S 3552, EPA pesticides and chemicals policies, including national ambient air quality rules, Globally Harmonized System of Classification and Labeling (GHS) regulations

Product safety and product care; public health and safety as part of TSCA, S. 847, S 1009

Toxic Substances Control Act: S. 1009, S 847, Pesticides Policy and Implementation of S 3552, EPA pesticides and chemicals policies, including national ambient air quality rules, Globally Harmonized System of Classification and Labeling (GHS) regulations

Toxic Substances Control Act: S. 1009, S 847, Pesticides Policy and Implementation of S 3552, EPA pesticides and chemicals policies, including national ambient air quality rules, Globally Harmonized System of Classification and Labeling (GHS) regulations

Toxic Substances Control Act [15 USC 2604][S. 847]; Consumer Products Safety and Information Act [CPSIA; HR 2715] Pesticides Registration Improvement Act [S. 3552]

TSCA and introduction of reauthorization legislation; HR 4159, the School Environment Protection Act

Pesticide regulations for non-agriculture products; PRIA ; Toxic Substances Control Act (HR 5820/S 3031), Global chemical regulatory policy: GHS and multilateral treaties (PICs and POPs).

Toxic Substances Control Act (HR 5820/S 3031), Global chemical regulatory policy: GHS and multilateral treaties (PICs and POPs)

Toxic Substances Control Act (S 3209, HR 5820)

Toxic Substances Control Act (HR 5820/S 3031), Global chemical regulatory policy: GHS and multilateral treaties (PICs and POPs)

Pesticide regulations for non-agriculture products; PRIA ; Toxic Substances Control Act (HR 5820/S 3031), Global chemical regulatory policy: GHS and multilateral treaties (PICs and POPs).

Consumer Product Ingredient Labeling; Drug-Free Communities Act (S 3031)

Toxic Substances Control Act (S 3209, HR 5820)

H.R. 6100, Kid-Safe Chemicals Act of 2008

H.R. 6100 Kid-Safe Chemicals Act of 2008

H.R. 6100 Kid-Safe Chemicals Act of 2008

H.R. 2474 To Provide for an increased maximum civil penalty for violations under the Consumer Product Safety Act S. 2045, CPSC Reform Act of 2007

H.R. 2474, To provide for an increased maximum civil penalty for violations under the Consumer Product Safety Act.

H.R. 2474, To Provide for an increased maximum civil penalty for violations under the Consumer Product Safety Act S. 2045, CPSC Reform Act of 2007

Environmental Protection Agency Funding to support the Pesticide Registration Improvement Act of 2003 FY08 Interior Appropriations Bill S. 1983, Pesticide Registration Improvement Renewal Act EPA's Proposed Risk Mitigation Decision for Nine Rodenticides

Environmental Protection Agency Funding to support the Pesticide Registration Improvement Act of 2003 FY08 Interior Appropriations Bill S. 1983, Pesticide Registration Improvement Renewal Act EPA's Proposed Risk Mitigation Decision for Nine Rodenticides

Environmental Protection Agency Funding to support the Pesticide Registration Improvement Act of 2003 FY08 Interior Appropriations Bill S. 1983, Pesticide Registration Improvement Renewal Act EPA's Proposed Risk Mitigation Decision for Nine Rodenticides

H.R. 2474 To Provide for an increased maximum civil penalty for violations under the Consumer Product Safety Act S. 2045, CPSC Reform Act of 2007

H.R. 2474, To Provide for an increased maximum civil penalty for violations under the Consumer Product Safety Act S. 2045, CPSC Reform Act of 2007